Medicare Enrolled

Dr. Hema Salvady, MD

Internal Medicine · Pearland, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
11555 MAGNOLIA PKWY, Pearland, TX 77584
2819579127
In practice since 2006 (19 years)
NPI: 1609962885 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Salvady from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Salvady? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Salvady

Dr. Hema Salvady is an internal medicine specialist in Pearland, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Salvady performed 2,204 Medicare services across 372 unique beneficiaries.

Between the years covered by Open Payments, Dr. Salvady received a total of $26,048 from 59 pharmaceutical and/or device companies across 1404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Salvady is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 16% volume in TX $26,048 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,204
Medicare services
Top 16% in TX for internal medicine
372
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~116 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,560 $18 $50
Office visit, established patient (30-39 min) 285 $89 $265
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 80 $58 $230
X-ray of hand, minimum of 3 views 58 $28 $132
Bone density scan (DEXA) 57 $39 $200
Injection, zoledronic acid, 1 mg 55 $7 $100
New patient office visit (45-59 min) 36 $127 $342
Office visit, established patient (20-29 min) 24 $70 $150
Injection, methylprednisolone acetate, 40 mg 24 $5 $20
Joint injection, major joint 14 $54 $200
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 11 $52 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
78.6% medium
20.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$26,048
Total received (2018-2024)
Avg $3,721/year across 7 years
Top 4% in TX for internal medicine
59
Companies
1,404
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,419 (97.6%)
Other
Charitable contributions, space rental, and other categories
$520 (2.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$109 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,131
2023
$3,674
2022
$3,384
2021
$3,289
2020
$3,038
2019
$4,659
2018
$4,874

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$4,043
AbbVie Inc.
$1,839
UCB, Inc.
$1,718
Janssen Biotech, Inc.
$1,536
PFIZER INC.
$1,503
Novartis Pharmaceuticals Corporation
$1,436
Lilly USA, LLC
$1,280
ABBVIE INC.
$1,219
E.R. Squibb & Sons, L.L.C.
$1,172
Mallinckrodt Hospital Products Inc.
$947
AbbVie, Inc.
$942
GlaxoSmithKline, LLC.
$900
Genentech USA, Inc.
$702
Horizon Therapeutics plc
$618
GENZYME CORPORATION
$618
AstraZeneca Pharmaceuticals LP
$617
Aurinia Pharma U.S., Inc.
$534
Welch Allyn
$520
Alexion Pharmaceuticals, Inc.
$437
Celgene Corporation
$329
Radius Health, Inc.
$237
Mallinckrodt LLC
$231
Horizon Pharma plc
$229
SANOFI-AVENTIS U.S. LLC
$180
Hikma Pharmaceuticals USA
$179
Mallinckrodt Enterprises LLC
$177
Fresenius Kabi USA, LLC
$177
ANI Pharmaceuticals, Inc.
$169
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
Antares Pharma, Inc.
$146
FIDIA PHARMA USA INC.
$143
Merck Sharp & Dohme Corporation
$97
Teva Pharmaceuticals USA, Inc.
$82
Organon LLC
$78
Sandoz Inc.
$66
MEDAC PHARMA, INC.
$65
MEDEXUS PHARMA, INC.
$61
Organon Llc
$55
Flexion Therapeutics, Inc.
$51
SOBI, INC
$44
Gilead Sciences, Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$43
Kyowa Kirin, Inc.
$43
Ironwood Pharmaceuticals, Inc
$40
TerSera Therapeutics LLC
$38
Fidia Pharma USA Inc.
$33
Sobi, Inc
$30
Bioventus LLC
$28
DePuy Synthes Sales Inc.
$26
Exeltis, USA Inc.
$25
West-Ward Pharmaceuticals
$22
Ultragenyx Pharmaceutical Inc.
$22
Actelion Pharmaceuticals US, Inc.
$19
Avanos Medical
$19
Bayer HealthCare Pharmaceuticals Inc.
$19
Kiniksa Pharmaceuticals International, plc
$19
Celltrion USA Inc.
$17
IBSA Pharma Inc.
$15
Cumberland Pharmaceuticals, Inc.
$12
Top 3 companies account for 29.2% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Adempas · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · DUZALLO · Dexilant · Durolane · EVENITY · EVUSHELD · Enbrel · FORTEO · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Licart · Mitigare · None · OFEV · OPSUMIT MACITENTAN · ORENCIA · ORTHOVISC · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REDITREX · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · TALTZ · TAVNEOS · TREMFYA · TRIVISC SODIUM HYALURONATE · Tavneos · Truxima · Tymlos · UPLIZNA · Uloric · XELJANZ · YUFLYMA · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in TX.

Equivalent to $1,182 per 100 Medicare services performed
Looking for an internal medicine specialist in Pearland?
Compare internal medicine physicians in the Pearland area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,355
Per 100K population
617.1
County median income
$95,155
Nearest hospital
HCA HOUSTON HEALTHCARE PEARLAND
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Salvady is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), with low-engagement industry engagement in the top 4% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Salvady experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Salvady performed 1,560 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Salvady receive payments from pharmaceutical companies?
Yes. Dr. Salvady received a total of $26,048 from 59 companies across 1,404 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Salvady's costs compare to other internal medicine physicians in Pearland?
Dr. Salvady's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Salvady) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →